Secondhand Smoke Exposure in Childhood and Adulthood in Relation to Adult Mortality Among Never Smokers

September 2018 Volume 55, Issue 3, Pages 345–352

W. Ryan Diver, MSPH'Eric J. Jacobs, PhD,Susan M. Gapstur, PhD
Epidemiology Research Program, American Cancer Society, Atlanta, Georgia
 

Introduction

Secondhand smoke is known to have adverse effects on the lung and vascular systems in both children and adults. It is unknown if childhood exposure to secondhand smoke is associated with adult mortality.

Methods

The authors examined associations of childhood and adult secondhand smoke exposure with death from all causes, ischemic heart disease, stroke, and chronic obstructive pulmonary disease among 70,900 never smoking men and women, predominantly aged ≥50 years, from the Cancer Prevention Study–II Nutrition Cohort in 1992–1993. There were 25,899 participant deaths during follow-up through 2014. During 2016–2017, Cox proportional hazards regression models were used to calculate multivariable-adjusted hazard ratios and 95% CIs.

Results

Childhood secondhand smoke exposure was not associated with all-cause mortality. However, childhood secondhand smoke (living with a smoker for 16–18 years during childhood) was associated with higher mortality from chronic obstructive pulmonary disease (hazard ratio=1.31, 95% CI=1.05, 1.65). Adult secondhand smoke exposure of ≥10 hours/week at enrollment was associated with a higher risk of all-cause (hazard ratio=1.09, 95% CI=1.04, 1.14); ischemic heart disease (hazard ratio=1.27, 95% CI=1.14, 1.42); stroke (hazard ratio=1.23, 95% CI=1.04, 1.45); and chronic obstructive pulmonary disease (hazard ratio=1.42, 95% CI=0.97, 2.09) mortality.

Conclusions

These results suggest that childhood secondhand smoke exposure, as well as adult secondhand smoke exposure, increase the risk of chronic obstructive pulmonary disease death in adulthood. Consistent with previous studies, the results also show that adult secondhand smoke is meaningfully associated with higher mortality from vascular disease and all causes. Overall, these findings provide further evidence for reducing secondhand smoke exposure throughout life.

PDF (337 KB)

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @Aller_MD: Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients htt…
1hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: @SeattleMamaDoc: '“Air Canada doesn’t have epi on board” (apparently too expensive - huh). Thankfully most food-al…
1hreplyretweetfavorite
Interasma Interasma - Effects of Macrolide Treatment during the Hospitalization of Children with Childhood Wheezing Disease:… https://t.co/XLMhnvQl5E
3hreplyretweetfavorite
Interasma RT @ARIAGuideline: Towards precision medicine in chronic rhinosinusitis. Prof. Dr. Benjamin Bleier, USA. https://t.co/ps5LKfOD6H
8hreplyretweetfavorite
Interasma RT @ARIAGuideline: First-line and second-line treatments for chronic sinusitis. An interview with Prof. Peter Hellings, Belgium https://t.c…
8hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma